CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | | | | | | Tissue enhanced |
EXOC3L2 | Exocyst complex component 3-like 2 | | | | | | Tissue enhanced |
FLRT3 | Fibronectin leucine rich transmembrane protein 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL17RB | Interleukin 17 receptor B | Predicted membrane proteins
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | | | | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PALM3 | Paralemmin 3 | | | | | | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PDZK1 | PDZ domain containing 1 | | | | | | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | | | | Tissue enhanced |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
SFXN2 | Sideroflexin 2 | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A9 | Solute carrier family 2 (facilitated glucose transporter), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SUGCT | SuccinylCoA:glutarate-CoA transferase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
SULT1C2 | Sulfotransferase family, cytosolic, 1C, member 2 | Plasma proteins
| | | | | Tissue enhanced |
SUSD2 | Sushi domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |